Clinical Trial Update: Efficacy and Safety Evaluation in Recurrent Wheezing Attacks [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety for recurrent wheezing attacks; results completed and posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis
• Bronchitis
• Bronchospasm

Snippet

Sponsor: Inmunotek S.L. | Conditions: Bronchospasm; Bronchiolitis, Bronchospasm; Bronchitis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-04